Brophy and Bally have expressed several concerns about our commentary¹ regarding their meta-analysis of observational studies of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarction, published in the BMJ.² We are grateful for the opportunity to respond to these concerns.

中文翻译：

---

对作者的评论重新评论：非甾体类抗炎药引起的心血管风险的新争议

Brophy和Bally对我们的评论¹进行了一些关注，这些评论是关于他们对使用非甾体抗炎药（NSAIDs）和心肌梗塞的观察性研究的荟萃分析，该评论发表在BMJ上。²我们很高兴有机会对这些关切作出回应。